Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Altomonte

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Investigation|July 1, 1991
Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m geneM Maio, M Altomonte, R Tatake, et al.
Breast Cancer Research and Treatment|January 14, 2000
Differential levels of soluble intercellular adhesion molecule-1 (sICAM-1) in early breast cancer and benign breast lesionsM Altomonte, E Fonsatti, E Lamaj, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|May 1, 1997
Triggering of HLA-DR antigens differentially modulates tumor necrosis factor alpha release by B cells at distinct stage of maturationS Coral, C Pucillo, A Leonardi, et al.
Cytokine|May 1, 1997
Biphasic control of NF-kappa B activation induced by the triggering of HLA-DR antigens expressed on B cellsA Leonardi, M Altomonte, M Maio, et al.
Cancer Research|July 15, 1993
Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cellsM Altomonte, A Gloghini, G Bertola, et al.
Thyroid : Official Journal of the American Thyroid Association|March 10, 1998
Intercellular adhesion molecule-1 is upregulated via the protein kinase C pathway in human thyroid carcinoma cell linesV Bassi, S De Riu, A Feliciello, et al.
American Journal of Clinical Oncology|December 1, 1996
Melanoma-associated hypopigmentation: where are the antibodies?O Merimsky, Y Shoenfeld, E Baharav, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 30, 1999
Prolonged upregulation of the expression of HLA class I antigens and costimulatory molecules on melanoma cells treated with 5-aza-2'-deoxycytidine (5-AZA-CdR)S Coral, L Sigalotti, A Gasparollo, et al.
Melanoma Research|October 1, 1995
Anti-tyrosinase antibodies participate in the immune response to vaccination with anti-idiotypic antibodies mimicking the high-molecular-weight melanoma-associated antigenE Baharav, O Merimsky, M Altomonte, et al.
British Journal of Cancer|January 1, 1997
Tumour-derived interleukin 1alpha (IL-1alpha) up-regulates the release of soluble intercellular adhesion molecule-1 (sICAM-1) by endothelial cellsE Fonsatti, M Altomonte, S Coral, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Investigation|July 1, 1991
Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m geneM Maio, M Altomonte, R Tatake, et al.
Breast Cancer Research and Treatment|January 14, 2000
Differential levels of soluble intercellular adhesion molecule-1 (sICAM-1) in early breast cancer and benign breast lesionsM Altomonte, E Fonsatti, E Lamaj, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|May 1, 1997
Triggering of HLA-DR antigens differentially modulates tumor necrosis factor alpha release by B cells at distinct stage of maturationS Coral, C Pucillo, A Leonardi, et al.
Cytokine|May 1, 1997
Biphasic control of NF-kappa B activation induced by the triggering of HLA-DR antigens expressed on B cellsA Leonardi, M Altomonte, M Maio, et al.
Cancer Research|July 15, 1993
Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cellsM Altomonte, A Gloghini, G Bertola, et al.
Thyroid : Official Journal of the American Thyroid Association|March 10, 1998
Intercellular adhesion molecule-1 is upregulated via the protein kinase C pathway in human thyroid carcinoma cell linesV Bassi, S De Riu, A Feliciello, et al.
American Journal of Clinical Oncology|December 1, 1996
Melanoma-associated hypopigmentation: where are the antibodies?O Merimsky, Y Shoenfeld, E Baharav, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 30, 1999
Prolonged upregulation of the expression of HLA class I antigens and costimulatory molecules on melanoma cells treated with 5-aza-2'-deoxycytidine (5-AZA-CdR)S Coral, L Sigalotti, A Gasparollo, et al.
Melanoma Research|October 1, 1995
Anti-tyrosinase antibodies participate in the immune response to vaccination with anti-idiotypic antibodies mimicking the high-molecular-weight melanoma-associated antigenE Baharav, O Merimsky, M Altomonte, et al.
British Journal of Cancer|January 1, 1997
Tumour-derived interleukin 1alpha (IL-1alpha) up-regulates the release of soluble intercellular adhesion molecule-1 (sICAM-1) by endothelial cellsE Fonsatti, M Altomonte, S Coral, et al.
Pageof 6